Historique
Auteur J. DUPOUY
Documents disponibles écrits par cet auteur (15)
Ajouter le résultat à votre sélection Affiner la recherche
J. DUPOUY | 2018
Dans Courrier des Addictions (Le) (Vol.20, n°3, Juillet-août-septembre 2018) Article : PériodiqueFRANÇAIS : La prise en charge du patient ayant un trouble de l'usage des opiacés (TUO) en médecine générale a permis depuis les années 90 la prise en charge de la majorité des patients sous médicament de substitution aux opiacés (MSO) avec des [...]
F. FORTIN ; S. ROCHE ; J. DUPOUY ; P. BERNARD ; J. LACHAL ; C. LAMBERT ; C. LAPORTE | 2022
Dans International Journal of Environmental Research and Public Health (Vol.19, n°20, October 2022) Article : PériodiqueAIMS: General practitioners (GPs), who are the most frequently consulted health professionals by adolescents, play a key role in screening for psychoactive substance (PAS) use. The purpose of our study was to determine the barriers and expectati[...]
L. T. GIMENEZ ; D. L. BONIS ; M. MOREL ; A. PALMARO ; L. DASSIEU ; J. DUPOUY | 2024
Dans Journal of Substance Use and Addiction Treatment (Vol.156, January 2024) Article : PériodiqueIntroduction: France has one of the highest opioid agonist treatment (OAT) coverage rates in the world. French general practitioners (GPs) are providing the majority of prescriptions. However, a fall in the number of GPs initiating buprenorphine[...]
A. SUD ; K. CHIU ; J. FRIEDMAN ; J. DUPOUY | 2023
Dans International Journal of Drug Policy (Vol.120, October 2023) Article : PériodiqueBackground: In passing the Maintstreaming Addiction Treatment Act, the United States has abolished its federal X waiver, considered a major barrier to the wider buprenorphine prescribing needed to respond to opioid-related harms. Advocates for t[...]
S. COSTE ; L. GIMENEZ ; A. COMES ; X. ABDELNOUR ; J. DUPOUY ; E. ESCOURROU | 2020
Dans BJGP Open (Vol.4, n°2, June 2020) Article : PériodiqueBACKGROUND: Despite most GPs recognising their role in the early diagnosis of alcohol use disorder (AUD), only 23% of GPs routinely screen for alcohol use. One reason GPs report for not screening is their relationship with patients; questions re[...]
J. DUPOUY ; V. MÉMIER ; H. CATALA ; M. LAVIT ; S. OUSTRIC ; M. LAPEYRE-MESTRE | 2014
Dans Drug and Alcohol Dependence (Vol.136, March 2014) Article : PériodiqueBACKGROUND: In the field of addiction, assessment of psychoactive substance use is a key element. Nevertheless, self-reports and clinical examination underestimate the use of psychoactive substances. The implementation of urine drug screening te[...]
J. DUPOUY ; L. DASSIEU ; R. BOURREL ; J. C. POUTRAIN ; S. BISMUTH ; S. OUSTRIC ; M. LAPEYRE-MESTRE | 2013
Dans Journal of Substance Abuse Treatment (Vol.44, n°5, May-June 2013) Article : PériodiqueWe aimed to assess the effectiveness of drug tests for treatment retention in outpatients starting opioid substitution therapy. A retrospective cohort was created from the data of the French health insurance system database for the Midi-Pyrene[...]
B. LEPINE ; M. DEBIN ; L. DASSIEU ; L. GIMENEZ ; A. PALMARO ; C. PONTE ; M. SWITAL ; M. LAPEYRE-MESTRE ; T. BLANCHON ; J. DUPOUY | 2024
Dans Therapies (Vol.79, n°6, Novembre-Décembre 2024) Article : PériodiqueIntroduction: France is a leading country for opioid agonist treatment providing, with a predominance of buprenorphine. General practitioners (GPs) are the main prescribers of buprenorphine, but they seem to be less involved over the last 10 yea[...]
L. POCHARD ; J. DUPOUY ; E. FRAUGER ; A. GIOCANTI ; J. MICALLEF ; M. LAPEYRE-MESTRE ; French Addictovigilance Network | 2018
Dans Fundamental and Clinical Pharmacology (Vol.32, n°2, April 2018) Article : PériodiquePregnancy can be a motivation for decrease in drug abusing but may also represent a period of high vulnerability for relapse. We aimed to assess psychoactive substance use among women with substance use disorders followed in addiction care cente[...]
J. DUPOUY ; S. BISMUTH ; S. OUSTRIC ; M. LAPEYRE-MESTRE | 2012
Dans European Addiction Research (Vol.18, n°4, June 2012) Article : PériodiqueIn France, opiate-addicted patients are mainly managed by general practitioners (GPs). Because on-site abuse drugs urinary screening tests (ODUTs) are now on the market, we investigated French GPs' knowledge and practices concerning drug tests w[...]
D. DRIOT ; E. JOUANJUS ; S. OUSTRIC ; J. DUPOUY ; M. LAPEYRE-MESTRE | 2019
Dans British Journal of Clinical Pharmacology (Vol.85, n°6, June 2019) Article : PériodiqueAIMS: The aim of this study was to assess the use and factors associated with the misuse of gabapentin and pregabalin in the general French population, through a cohort study in the EGB (General Sample of Beneficiaries), a national representativ[...]
B. LEPINE ; M. DEBIN ; L. DASSIEU ; L. GIMENEZ ; A. PALMARO ; C. PONTE ; M. SWITAL ; M. LAPEYRE-MESTRE ; T. BLANCHON ; J. DUPOUY | 2022
Dans Journal of Substance Abuse Treatment (Vol.143, December 2022) Article : PériodiqueIntroduction: Although opioid substitution coverage in France is high and patient care with buprenorphine is mainly managed by general practitioners (GPs), buprenorphine sales have been decreasing since 2011, suggesting that French GPs are presc[...]
J. DUPOUY ; S. MAUMUS-ROBERT ; Y. MANSIAUX ; A. PARIENTE ; M. LAPEYRE-MESTRE | 2020
Dans European Addiction Research (Vol.26, n°6, November 2020) Article : PériodiqueBACKGROUND: In France, most patients with opioid use disorder (OUD) have been treated by buprenorphine, prescribed by general practitioners (GP) in private practice since 1996. This has contributed to building a 'French model' facilitating acces[...]
E. JOUANJUS ; M. LAPEYRE-MESTRE ; M. NODOT ; A. ROUSSIN ; N. FRANCHITTO ; J. P. BOYES ; N. NASR ; S. OUSTRIC ; J. DUPOUY | 2019
Dans Clinical Therapeutics (Vol.41, n°10, October 2019) Article : PériodiquePurpose: Recent evolution toward a medical perspective on patients with substance use disorders (SUDs) has led to a lack of medical training in substance abuse. To increase this knowledge, a distance learning course ("e-learning") was implemente[...]
